Send me a link:

*Text messaging rates may apply.

 Dow Up 0.13% Nasdaq Down 0.10%

Anthera Pharmaceuticals, Inc. (ANTH)

-NasdaqGM
3.00 0.06(1.96%) Jul 28, 4:00PM EDT
Prev Close:3.06
Open:3.06
Bid:2.85 x 5300
Ask:3.25 x 1900
1y Target Est:8.17
Beta:1.24
Earnings Date:Oct 27 - Oct 31 (Est.)
Day's Range:2.95 - 3.08
52wk Range:2.54 - 4.60
Volume:198,396
Avg Vol (3m):157,168
Market Cap:62.66M
P/E (ttm):N/A
EPS (ttm):-1.61
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ANTH

Comparison

Symbol% ChgMkt Cap
ANTHDown 1.96%62.66M
BIIB79.44B
GSK115.78B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.93
Quarterly EPS Est (Sep-14) :-0.31
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing products to treat diseases associated with inflammation and autoimmune diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback